SCHEMBL19420239

SCHEMBL19420239

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-n4c5ccccc5c5cc(-c6ccccc6)ccc54)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ TSPO P30536 4/20 0.47
▸ HDAC4 P56524 1/20 0.41
▸ RAC2 P15153 1/20 0.37
▸ RAC3 P60763 1/20 0.37
▸ CDC42 P60953 1/20 0.37
▸ RAC1 P63000 1/20 0.37
▸ PTGER4 P35408 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ DNM1 Q05193 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ PTPN1 P18031 2/20 0.34
▸ NR3C1 P04150 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17122302 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17122284 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL13803252 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL24221771 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17122282 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL24221749 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL16904443 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17722309 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL10001494 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17122303 1.00 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11925111-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2024-03-05 — — US disclosed
US-11925111-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2024-03-05 — — US disclosed
US-20240074307-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-29 — — US disclosed
US-20240074307-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-29 — — US disclosed
US-20220029102-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-27 — — US disclosed
US-10734586-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-04 — — US disclosed
US-20170288147-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-05 — — US disclosed
US-20170288147-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170288147-A1 ORGANIC LIGHT EMITTING DEVICE SUN2, CYBA, SLC25A21 L3MBTL1 1491/4885KDM4E 3633/4885ATM 2614/4885
US-20240074307-A1 ORGANIC LIGHT EMITTING DEVICE SUN2, CYBA, SLC25A21 L3MBTL1 1491/4885KDM4E 3633/4885ATM 2614/4885
US-11925111-B2 Organic light emitting device SUN2, CYBA, SLC25A21 L3MBTL1 1491/4885KDM4E 3633/4885ATM 2614/4885
US-20220029102-A1 ORGANIC LIGHT EMITTING DEVICE SUN2, CYBA, SLC25A21 L3MBTL1 1491/4885KDM4E 3633/4885ATM 2614/4885
US-10734586-B2 Organic light emitting device SUN2, CYBA, SLC25A21 L3MBTL1 1491/4885KDM4E 3633/4885ATM 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback